These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18180061)

  • 21. Hemorheological disorders and arteriolar resistance during ischemic heart disease.
    Urdulashvili T; Momtselidze N; Mantskava M; Narsia N; McHedlishvili G
    Clin Hemorheol Microcirc; 2004; 30(3-4):399-401. PubMed ID: 15258372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urocortin].
    Shibasaki T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():637-9. PubMed ID: 20963898
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities for cardiovascular gene therapy].
    Szelid ZL; Pokreisz P; Janssens S; Polák G
    Orv Hetil; 2005 May; 146(22):1189-96. PubMed ID: 15997664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of NHE-1 in myocardial hypertrophy and remodelling.
    Karmazyn M; Kilić A; Javadov S
    J Mol Cell Cardiol; 2008 Apr; 44(4):647-53. PubMed ID: 18329039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter regarding article by Rademaker et al, "integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure".
    Takahashi K
    Circulation; 2006 Apr; 113(15):e710; author reply e710. PubMed ID: 16618827
    [No Abstract]   [Full Text] [Related]  

  • 26. Urocortins: Actions in health and heart failure.
    Rademaker MT; Richards AM
    Clin Chim Acta; 2017 Nov; 474():76-87. PubMed ID: 28887029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
    Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
    Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann T; Kloner RA
    Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling.
    Calderón-Sánchez EM; Falcón D; Martín-Bórnez M; Ordoñez A; Smani T
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urocortin 2 in cardiovascular health and disease.
    Adão R; Santos-Ribeiro D; Rademaker MT; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2015 Jul; 20(7):906-14. PubMed ID: 25748088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical animal models of heart failure related to coronary heart disease.
    Klocke R; Tian W; Kuhlmann MT; Nikol S
    Cardiovasc Res; 2007 Apr; 74(1):29-38. PubMed ID: 17188668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat.
    Szabadfi K; Atlasz T; Reglodi D; Kiss P; Dányádi B; Fekete EM; Zorrilla EP; Tamás A; Szabó K; Gábriel R
    Neurosci Lett; 2009 May; 455(1):42-5. PubMed ID: 19429103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models of myocardial and vascular injury.
    Abarbanell AM; Herrmann JL; Weil BR; Wang Y; Tan J; Moberly SP; Fiege JW; Meldrum DR
    J Surg Res; 2010 Aug; 162(2):239-49. PubMed ID: 20053409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress?
    Cook AR; Bardswell SC; Pretheshan S; Dighe K; Kanaganayagam GS; Jabr RI; Merkle S; Marber MS; Engelhardt S; Avkiran M
    J Mol Cell Cardiol; 2009 Feb; 46(2):225-33. PubMed ID: 19027022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
    Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
    Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure.
    Tang WH; Shrestha K; Martin MG; Borowski AG; Jasper S; Yandle TG; Richards AM; Klein AL; Troughton RW
    J Card Fail; 2010 Aug; 16(8):635-40. PubMed ID: 20670842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew.
    Kozicz T; Bordewin LA; Czéh B; Fuchs E; Roubos EW
    Psychoneuroendocrinology; 2008 Jul; 33(6):741-54. PubMed ID: 18394812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.